Indian Pharma sees decline in August 2020, anti-infectives, respiratory segments see major slumps: AIOCD-AWACS report Farhat Nasim12 Sept 2020 1:08 PM ISTNew Delhi: Amid the ongoing COVID-19 crisis, the month of August remained unfavorable for the Indian pharmaceutical market as data from market...
CDSCO commmitee nod to Cipla, Optimus phase 4 trials of COVID drug favipiravir Farhat Nasim11 Sept 2020 3:00 PM ISTNew Delhi: Drug major Cipla Ltd and Optimus Pharma have recently secured permission from the expert's panel of Central Drugs Standard Control...
PIL against 10 top pharma Cos in SC alleging sale of Remdesivir and Favipiravir without valid license Ruchika Sharma7 Sept 2020 1:26 PM ISTIt has also made 10 pharmaceutical companies, including Cipla Ltd, Dr Reddy's Laboratories Ltd, Hetero Labs Ltd and Zydus Cadila Healthcare Ltd,...
Cipla, Stempeutics join hands for critical limb ischemia treatment in India Ruchika Sharma21 Aug 2020 12:14 PM ISTThe product is indicated for the treatment of CLI due to Buerger''s disease and atherosclerotic peripheral arterial disease, it added.
Cipla collaborating with CSIR, IICT, ICMR, Health Ministry to develop treatment for COVID-19 Ruchika Sharma6 Aug 2020 2:07 PM ISTNew Delhi: Drug major Cipla is working with government agencies to develop a treatment for COVID-19 while ramping up the production of various...
ANI Pharma appoints Nikhil Lalwani as new President, Chief Executive Officer Ruchika Sharma5 Aug 2020 4:50 PM ISTBaudette: ANI Pharmaceuticals, Inc. has announced that Nikhil Lalwani has been named the Company's President and Chief Executive Officer,...
Mega Exit: Cipla India top boss, 2 senior executives step out after 24 year stint Farhat Nasim5 Aug 2020 12:45 PM ISTMumbai: The sudden exit of top executives of drug major Cipla Ltd. has come as a major shock; wherein; Nikhil Chopra, the company's chief executive of...
Avra Labs secures CDSCO nod to manufacture, market Favipiravir API Ruchika Sharma28 July 2020 12:11 PM ISTHyderabad: Avra Laboratories Pvt Ltd, a city based pharma company, has been granted regulatory approval by the Central Drugs Standard Control...
NPPA revises ceiling price of Budesonide upholding DOP review order; Details Farhat Nasim26 July 2020 11:15 AM ISTNew Delhi: In an implementation of directions given in line with review orders issued by the Department of Pharmaceuticals (DOP), the National...
Cipla to soon unveil COVID drug Ciplenza for Rs 68 MD Bureau25 July 2020 11:00 AM ISTCipla said it will commercially launch Ciplenza in the first week of August priced at Rs 68 per tablet.
Cipla to launch affordable COVID-19 drug Favipiravir Ruchika Sharma24 July 2020 12:50 PM ISTAn off-patent anti-viral drug, Favipiravir, originally discovered by Fuji Pharma in Japan, has shown promise in clinical trials for the treatment of...
Cipla settles case with Amgen involving generic Cinacalcet Hydrochloride Tablets Ruchika Sharma22 July 2020 2:19 PM ISTNew Delhi: The drug major has reached a settlement with Amgen Inc on pending litigation involving generic cinacalcet hydrochloride tablets. The civil...
